Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Gavaris Leads Lupin In US Ahead Of Core Spiriva Strategy
Indian Firm Expecting Gx Tiotropium To Be Major Catalyst For Growth
Dec 12 2022
•
By
Dean Rudge
Lupin is looking to revitalize its US business • Source: Andrii Yalanskyi / Alamy Stock Photo
More from Leadership
More from Generics Bulletin